CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-23 | Lefebvre Eric Chief Medical Officer | Grant or award | +45,650 | 240,224 | ||
| 2025-01-23 | Lefebvre Eric Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +91,300 | 91,300 | ||
| 2025-01-17 | Lefebvre Eric Chief Medical Officer | Sale 10b5-1 | −18,478 | $11.20 | $207K | 194,574 |
| 2024-07-10 | Lefebvre Eric Chief Medical Officer | Sale 10b5-1 | −12,319 | $11.56 | $142K | 213,052 |
| 2024-07-09 | Lefebvre Eric Chief Medical Officer | Grant or award | +24,063 | 225,371 | ||
| 2024-01-23 | Lefebvre Eric Chief Medical Officer | Grant or award | +42,900 | 199,820 | ||
| 2024-01-23 | Lefebvre Eric Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +85,800 | 85,800 | ||
| 2024-01-17 | Lefebvre Eric Chief Medical Officer | Sale 10b5-1 | −10,295 | $17.23 | $177K | 156,920 |
| 2023-07-17 | Lefebvre Eric Chief Medical Officer | Sale 10b5-1 | −22,321 | $18.01 | $402K | 167,215 |
| 2023-07-14 | Lefebvre Eric Chief Medical Officer | Grant or award | +43,750 | 189,536 | ||
| 2023-03-30 | Lefebvre Eric Chief Medical Officer | Sale 10b5-1 | −11,245 | $26.52 | $298K | 145,786 |
| 2023-03-29 | Lefebvre Eric Chief Medical Officer | Grant or award | +21,874 | 157,031 | ||
| 2023-01-25 | Lefebvre Eric Chief Medical Officer | Grant or award | +57,000 | 133,926 | ||
| 2023-01-25 | Lefebvre Eric Chief Medical Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2023-01-23 | Lefebvre Eric Chief Medical Officer | Sale | −67,500 | $34.48 | $2.3M | 76,926 |
| 2022-12-20 | Lefebvre Eric Chief Medical Officer | Sale | −10,887 | $19.10 | $208K | 144,426 |
| 2022-12-19 | Lefebvre Eric Chief Medical Officer | Grant or award | +21,876 | 155,313 | ||
| 2022-10-25 | Lefebvre Eric Chief Medical Officer | Sale | −5,000 | $25.05 | $125K | 133,437 |
| 2022-07-11 | Lefebvre Eric Chief Medical Officer | Sale | −3,000 | $20.00 | $60K | 138,436 |
| 2022-01-26 | Lefebvre Eric Chief Medical Officer | Grant or award · Stock Option (right to buy) | +140,000 | 140,000 |
Page 1 of 2 · 28 trades